Clinical Trial Update: The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A two-phase clinical trial evaluating pomalidomide and bendamustine with dexamethasone for relapsed or refractory multiple myeloma is reported in early-phase ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Relapsed, Refractory, Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN